JP2008510006A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510006A5
JP2008510006A5 JP2007527895A JP2007527895A JP2008510006A5 JP 2008510006 A5 JP2008510006 A5 JP 2008510006A5 JP 2007527895 A JP2007527895 A JP 2007527895A JP 2007527895 A JP2007527895 A JP 2007527895A JP 2008510006 A5 JP2008510006 A5 JP 2008510006A5
Authority
JP
Japan
Prior art keywords
methyl
tetrahydro
benzimidazol
piperazinyl
quinolinamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007527895A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008510006A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/028811 external-priority patent/WO2006023400A2/en
Publication of JP2008510006A publication Critical patent/JP2008510006A/ja
Publication of JP2008510006A5 publication Critical patent/JP2008510006A5/ja
Pending legal-status Critical Current

Links

JP2007527895A 2004-08-16 2005-08-12 化合物 Pending JP2008510006A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60192804P 2004-08-16 2004-08-16
PCT/US2005/028811 WO2006023400A2 (en) 2004-08-16 2005-08-12 Chemical compounds

Publications (2)

Publication Number Publication Date
JP2008510006A JP2008510006A (ja) 2008-04-03
JP2008510006A5 true JP2008510006A5 (cg-RX-API-DMAC7.html) 2008-10-02

Family

ID=35968075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527895A Pending JP2008510006A (ja) 2004-08-16 2005-08-12 化合物

Country Status (18)

Country Link
US (1) US20080045537A1 (cg-RX-API-DMAC7.html)
EP (1) EP1789045A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008510006A (cg-RX-API-DMAC7.html)
KR (1) KR20070042568A (cg-RX-API-DMAC7.html)
CN (1) CN101039672A (cg-RX-API-DMAC7.html)
AR (1) AR050522A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005277638A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514438A (cg-RX-API-DMAC7.html)
CA (1) CA2577100A1 (cg-RX-API-DMAC7.html)
IL (1) IL181160A0 (cg-RX-API-DMAC7.html)
MA (1) MA28814B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007001958A (cg-RX-API-DMAC7.html)
NO (1) NO20071161L (cg-RX-API-DMAC7.html)
PE (1) PE20060646A1 (cg-RX-API-DMAC7.html)
RU (1) RU2350604C2 (cg-RX-API-DMAC7.html)
TW (1) TW200619217A (cg-RX-API-DMAC7.html)
WO (1) WO2006023400A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200701282B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7728026B2 (en) 2005-04-11 2010-06-01 Abbott Laboratories, Inc. 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
WO2007049771A1 (ja) 2005-10-28 2007-05-03 Ono Pharmaceutical Co., Ltd. 塩基性基を含有する化合物およびその用途
PT1961744E (pt) 2005-11-18 2013-05-15 Ono Pharmaceutical Co Composto que contém um grupo básico e sua utilização
US8618122B2 (en) 2006-05-16 2013-12-31 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
WO2008016006A1 (fr) 2006-07-31 2008-02-07 Ono Pharmaceutical Co., Ltd. Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
AR066162A1 (es) * 2007-07-31 2009-07-29 Bayer Cropscience Sa Derivados fungicidas de n- cicloalquil -n- carboxamida- biciclica
WO2010098866A1 (en) 2009-02-27 2010-09-02 Supergen, Inc. Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors
JP5541454B2 (ja) * 2009-09-16 2014-07-09 Jsr株式会社 液晶配向剤および液晶表示素子
JP5712524B2 (ja) * 2009-10-28 2015-05-07 Jsr株式会社 液晶配向剤および液晶表示素子
KR101594002B1 (ko) 2010-10-06 2016-02-15 글락소스미스클라인 엘엘씨 Pi3 키나제 억제제로서의 벤즈이미다졸 유도체
CN102675305B (zh) * 2011-03-08 2014-11-12 中国科学院上海药物研究所 一类咪唑并吡啶类化合物及其制备方法和用途
CN103570683B (zh) * 2012-07-30 2018-04-17 中国科学院上海药物研究所 多取代胺类化合物及其制备方法和用途
CN109069486A (zh) 2015-12-14 2018-12-21 X4 制药有限公司 治疗癌症的方法
CN109069426B (zh) 2015-12-14 2021-10-29 X4 制药有限公司 治疗癌症的方法
US10610527B2 (en) 2015-12-22 2020-04-07 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
US11337969B2 (en) 2016-04-08 2022-05-24 X4 Pharmaceuticals, Inc. Methods for treating cancer
US10988465B2 (en) 2016-06-21 2021-04-27 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
EP3808748B1 (en) 2016-06-21 2026-05-20 X4 Pharmaceuticals, Inc. Substituted piperidines as cxcr4-inhibitors
JP6994767B2 (ja) 2016-06-21 2022-01-14 エックス4 ファーマシューティカルズ, インコーポレイテッド Cxcr4阻害剤およびその使用
US11497744B2 (en) 2017-02-21 2022-11-15 Emory University Chemokine CXCR4 receptor modulators and uses related thereto
US11396501B2 (en) * 2017-09-25 2022-07-26 Cgenetech (Suzhou, China) Co., Ltd. Heteroaryl compounds as CXCR4 inhibitors, composition and method using the same
KR102678977B1 (ko) * 2017-09-25 2024-06-28 씨젠테크 (쑤저우, 차이나) 컴퍼니 리미티드 Cxcr4 저해제로서 헤테로아릴 화합물, 그 조성물 및 이용 방법
EP3768256A4 (en) 2018-03-19 2021-11-24 Emory University PAN-TROPICAL ENTRANCE INHIBITORS
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
CN115515585A (zh) 2020-03-10 2022-12-23 X4 制药有限公司 用于治疗中性粒细胞减少症的方法
WO2023003862A1 (en) 2021-07-19 2023-01-26 Emory University Cxcr4 modulators and uses related thereto

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524421A (en) * 2000-09-15 2005-02-25 Anormed Inc Chemokine receptor binding heterocyclic compounds
JP2004512336A (ja) * 2000-09-15 2004-04-22 アノーメッド インコーポレイティド ケモカインレセプター結合複素環式化合物
RU2289581C2 (ru) * 2000-09-15 2006-12-20 Анормед, Инк. Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение
KR20030034184A (ko) * 2000-09-15 2003-05-01 아노르메드 인코포레이티드 케모킨 수용체 결합 헤테로사이클릭 화합물
CA2467718C (en) * 2001-12-21 2011-04-26 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
US7332605B2 (en) * 2004-03-15 2008-02-19 Anormed, Inc. Process for the synthesis of CXCR4 antagonist

Similar Documents

Publication Publication Date Title
JP2008511668A5 (cg-RX-API-DMAC7.html)
US11905283B2 (en) Compounds and compositions for inhibiting the activity of SHP2
EP3788050B1 (en) C26-linked rapamycin analogs as mtor inhibitors
RU2351592C2 (ru) Производные тетрагидрохинолина и фармацевтическая композиция на их основе для лечения и профилактики вич-инфекции
US11529347B2 (en) SHP2 phosphatase inhibitors and methods of use thereof
KR101970837B1 (ko) 항바이러스제로서의 피라졸로[1,5-a]피리미딘
JP2023552864A5 (cg-RX-API-DMAC7.html)
JP2008511669A5 (cg-RX-API-DMAC7.html)
RU2486188C9 (ru) СОЕДИНЕНИЯ ИМИДАЗО[1,2-B]ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО[1,2-b]ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С ИНГИБИРОВАНИЕМ ГАМКА РЕЦЕПТОРОВ
CA3098692A1 (en) C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors
US10786492B2 (en) Formylated N-heterocyclic derivatives as FGFR4 inhibitors
CA3085346A1 (en) Amide substituted indole compounds useful as tlr inhibitors
JP2008516973A5 (cg-RX-API-DMAC7.html)
CN108366992A (zh) 蛋白水解靶向嵌合体化合物及其制备和应用方法
CN106413716A (zh) 通过jak和pi3k抑制剂组合治疗b细胞恶性肿瘤
TW201706251A (zh) 苯并咪唑及咪唑并吡啶甲脒化合物
RU2010116759A (ru) Пиримидиновые производные, используемые в качестве ингибиторов протеинкиназы
JP2007510649A5 (cg-RX-API-DMAC7.html)
WO2019034153A1 (zh) 一种化合物,其药物组合物及其用途及应用
JP7712942B2 (ja) トール様受容体7(TLR7)アゴニストとしての1H-ピラゾロ[4,3-d]ピリミジン化合物
WO2010053127A1 (ja) α1GABAA受容体またはα5GABAA受容体の調整剤
JP2008533082A5 (cg-RX-API-DMAC7.html)
JP2024537882A5 (cg-RX-API-DMAC7.html)
TW202321248A (zh) 酪胺酸激酶抑制劑
JP2025524064A (ja) Akr1c3依存性kars阻害剤の結晶形態